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Murine monoclonal antibodies (MAbs) were produced which were specific for Pasteurella haemolytica
serotype 1 lipopolysaccharide (LPS). The MAbs also reacted with LPS present in a partially purified antigen
derived from a saline extract of the organism. The epitope to which the MAbs were directed was a carbohydrate
which was sensitive to oxidation with periodate, had a molecular weight between 14,000 and 25,000 as
determined by immunoblotting, and was present in a crude 0-antigen preparation of P. haemolytica LPS. The
MAbs did not react with purified capsular polysaccharide from P. haemolytica serotype 1. In an enzyme-linked
immunosorbent assay, reaction of the MAbs with LPS obtained from 14 gram-negative bacteria failed to detect
any cross-reactivity with P. haemolytica LPS. However, the MAbs detected antigenic similarities among P.
haemolytica serotypes 1, 5, 6, 7, 8, and 12 and, to a lesser extent, 4 and 14. These studies indicate that the
LPS-O-antigens from several P. haemolytica serotypes have similar epitopes and may be partially responsible
for shared antigenicity among serotypes.
Pasteurella haemolytica biotype A, serotype 1, is the
major cause of bovine pneumonic pasteurellosis, a severe
fibrinous pneumonia of feedlot cattle (11). P. haemolytica
serotype 2 is frequently isolated from the nasal cavity of
healthy cattle (18, 19), whereas other serotypes are isolated
less frequently from cattle.
Lipopolysaccharide (LPS) is perhaps one of the most
important constituents of the gram-negative cell wall and is
well known for its biological activities, including modifica-
tion of metabolic activity and phagocytic function (24),
alteration of migration of neutrophils (26) and macrophages
(31), and mitogenesis of lymphocytes (29). Similar biological
activities have been associated with LPS from P. haemoly-
tica serotype 1 (13, 17, 35).
The typical LPS molecule is composed of three regions
consisting of lipid A, core oligosaccharides, and 0-antigen
polysaccharides. In contrast to the core oligosaccharide,
which is structurally similar among many gram-negative
bacteria, the 0-antigen is more chemically diverse among
bacteria and is highly antigenic (30). However, it is the
0-antigen which is responsible for the serological cross-
reactivity among certain gram-negative organisms; for ex-
ample, antibodies to Yersinia enterocolitica (serotype 0:9)
cross-react with Brucella abortus (7, 8) and antibodies to
Brucella abortus cross-react with Escherichia coli (0:157)
(37). Cross-reactivity among serotypes of a bacterial species
can also be contributed to the diversity of LPS, such as that
seen with Legionella pneumophila (10) and Pasteurella
multocida (34).
The antigenic diversity of P. haemolytica has led to the
identification of at least 15 serotypes based on capsular
antigens as determined by indirect hemagglutination (3),
agglutination (20), nucleic acid homology (2), and polyacryl-
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amide electrophoresis (38). This manuscript reports the
characterization of monoclonal antibodies (MAbs) to P.
haemolytica serotype 1 LPS and demonstrates antigenic
cross-reactivity of LPS among several P. haemolytica se-
rotypes.
MATERIALS AND METHODS
Bacterium. P. haemolytica biotype A, serotype 1, was
originally obtained from a feedlot calf and maintained as
described previously (32). Serotypes 5 and 9 were isolated
from tracheal swabs of feedlot cattle showing symptoms of
respiratory disease (George Burrows, College of Veterinary
Medicine, Oklahoma State University, Stillwater). Se-
rotypes 2, 3, 4, 6, 7, 8, 10, 11, 12, and 13 and an untypable
strain were obtained from Glynn Frank (National Animal
Disease Center [NADC], Ames, Iowa). Serotypes 14 and 15
were obtained from Michael Collier (University of Wiscon-
sin, Madison).
Immunizing antigen. Antigenic material was extracted
from logarithmic-phase P. haemolytica by using phosphate-
buffered saline (PBS) as described previously (21). The
extract was subjected to chromatofocusing, and the initial
antigenic peak was pooled and concentrated (28). This peak,
termed carbohydrate-protein subunit (CPS), is a high-molec-
ular-weight (>200,000) complex carbohydrate-protein com-
pound (16). The 2-keto-3-deoxyoctonate-protein ratio is vari-
able among lots, ranging from <0.1 to 5.3 ,ug/ml. The
protein-carbohydrate ratio ranges from 0.6 to 2.1.
LPS. LPS was obtained from P. haemolytica serotype 1 by
the phenol-water extraction method of Westphal and Jann
(40). The resulting LPS was determined to be antigenic by an
enzyme-linked immunosorbent assay (ELISA) that detects
P. haemolytica antigens (28). Lyophilized LPS was recon-
stituted in distilled water to a concentration of 5 mg (dry
weight) per ml. The LPS contained 0.45 mg of 2-keto-3-
deoxyoctonate per ml, 6.5 x 104 U of endotoxin per ml (13),
and undetectable protein content (<0.1 ,ug of protein per ml)
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Vol. 26, No. 5
886 DURHAM ET AL. J. CLIN. MICROBIOL.
(5). Polyacrylamide gel electrophoresis (PAGE) and silver
staining results of the LPS were consistent with patterns for
other bacterial LPS (S. Muir, personal communication). To
separate lipid A and the 0-antigen, the LPS was acid
hydrolyzed by the procedure of Grollman and Osborn (23).
Capsular polysaccharide. Serotype-specific capsular poly-
saccharide was isolated from P. haemolytica serotype 1 as
described (1). The protein content was <1% by weight (5).
By nuclear magnetic resonance spectroscopy, the polysac-
charide structure was found to be identical to that previously
described for P. haemolytica serotype 1 (A. Mort, unpub-
lished data).
MAb production. MAbs were produced as described by
Cunningham and Russell (14) and Goding (22). Six-week-old
male BALB/c mice were immunized intraperitoneally four
times at 2-week intervals with 0.2 ml of an emulsion con-
taining equal volumes of CPS (100 ,ug [dry weight] per
mouse) and Freund complete adjuvant, given with the first
injection, or Freund incomplete adjuvant, given with later
injections. Four days before fusion, the mice were injected
intraperitoneally with 200,ug of CPS in sterile PBS. This was
followed by a daily injection of 400 ,ug of CPS for the next 3
days. Mice that were not sacrificed for the fusion were bled
for positive control serum. Negative control serum was
obtained from age- and sex-matched BALB/c control mice.
After removal, spleens were minced and rinsed in Iscove
modified Dulbecco medium (IMDM) (Gibco Laboratories,
Grand Island, N.Y.) containing antibiotics as described
previously (14). Spleen cells were mixed at a 1:1 ratio with
murine myeloma cells (x63-Ag8.6.5.3) in 35% sterile poly-
ethylene glycol (pH 8.5). Following fusion, the cells were
centrifuged and resuspended in IMDM with antibiotics and
20% fetal bovine serum (HyClone, Logan, Utah) as de-
scribed by Cunningham and Russell (14). Cell cultures were
fed with IMDM containing 20% fetal bovine serum, 5 mM
hypoxanthine, 0.02 mM aminopterin, and 0.8 mM thymidine
(Sigma Chemical Co., St. Louis, Mo.). Hybridomas were
cloned three times by limiting dilution at <1 cell per well.
ELISA. An ELISA was used to screen culture superna-
tants for antibody reactive with CPS by the method of Voller
et al. (Dynatech Laboratories, Inc., Alexandria, Va.). The
optimal antigen and reagent concentrations were determined
by a checkerboard titration method (S. M. Antone, M.S.
thesis, Oklahoma State University, Stillwater, 1986).
Briefly, microdilution wells were coated with 0.5 ,ug of CPS
and washed after each step of incubation with PBS contain-
ing 0.05% Tween 20, pH 7.2 (PBS-Tween). Positive and
negative control mouse sera diluted 1:500 in PBS-Tween
containing 1% bovine serum albumin and culture superna-
tants were reacted with CPS-coated wells. Alkaline phos-
phatase-conjugated goat anti-mouse immunoglobulin (Sigma
Chemical Co.) was then reacted with the wells, and the
reaction was developed by using p-nitrophenyl phosphate (1
mg/ml) in diethanolamine hydrochloride (pH 9.6) and 1 mM
MgCl2. After a 30-min incubation, the reaction was stopped
with 3 N NaOH, and the A405 was determined (model
EL307; Bio-Tek Instruments, Inc., Burlington, Vt.). The
antibody-producing hybridomas were considered positive
when the well tested attained an A405 value of at least 0.5.
MAb reactivity to carbohydrate- and non-carbohydrate-
influenced epitopes in the CPS was performed in the ELISA
by the periodate oxidation technique described by Woodard
et al. (41).
SDS-PAGE and immunoblotting. Discontinuous sodium
dodecyl sulfate (SDS)-PAGE consisting of a 2% acrylamide
stacking gel and a 10% acrylamide resolving gel (27) was
used to separate the different antigen preparations. Electro-
phoretic transfer of proteins to a nitrocellulose membrane
was performed in a Mini Transphor TE22 (Hoefer Scientific
Instruments, San Francisco, Calif.) by the procedure of
Towbin et al. (39).
The antigens were detected immunoenzymatically follow-
ing consecutive incubations with MAb supernatant, biotiny-
lated protein A (1:300) (Amersham Corp., Arlington
Heights, Iii.), and streptavidin-horseradish peroxidase com-
plex (1:400) (Amersham). Antigenic bands were observed
following incubation in a solution of 0.5 mg of 4-chloro-1-
naphthol per ml in PBS containing 0.03% H202. The reaction
was stopped by the addition of distilled water, and the blots
were allowed to air dry.
Isotyping and quantitation of immunoglobulin. The
isotype of the MAbs was determined by an ELISA with a
mouse monoclonal subisotyping kit containing rabbit anti-
mouse immunoglobulin Gi (IgGl), IgG2a, IgG2b, IgG3,
IgM, and IgA (HyClone Laboratories). The immunoglobulin
concentration of the culture supernatants was determined in
an ELISA (36); the concentrations were extrapolated from a
regression line established by using A405 values and concen-
trations of a purified mouse IgG3 standard (Chemicon Inter-
national, Inc., El Segundo, Calif.).
Bacterial species and P. haemolytica serotype specificity.
The ELISA was used to determine whether the hybridoma
supernatants recognized LPS from other gram-negative bac-
teria. LPSs from Escherichia coli (serotypes 026:B6, 055:
B5, 0111:B4, 0127:B8, 0128:B12, J5, and EH100), Salmo-
nella typhimurium, Serratia marcescens (Sigma Chemical
Co.), Proteus vulgaris, Klebsiella pneumoniae (RIBI Corp.,
Hamilton, Mont.), Brucella abortus 19 and 2308 (M. Phiilips,
NADC), and Pasteurella multocida type 3 (R. Rimler,
NADC) were used to coat microtiter plates at 10 ,ug/ml.
Culture supernatants and control sera were incubated for 1
h, and then alkaline phosphatase-conjugated goat anti-mouse
immunoglobulin was added at a 1:200 dilution for 1 h. The
remaining procedure was as described above.
Formalinized P. haemolytica serotypes 1 through 15 and
an untypable strain were used to coat microtiter plates. The
reaction of the MAbs to the various serotypes was detected
by the ELISA as described above. Formalinized whole-cell
preparations of P. haemolytica serotypes 1, 2, 5, 6, 9, and an
untypable strain were separated by electrophoresis, trans-
ferred to nitrocellulose, and reacted with the antibody su-
pernatants as described above.
RESULTS
Three hybridomas which produced antibodies to CPS, as
determined by high A405 values, were cloned by limiting
dilution and designated ElF1O, H6B5, and H12E11. The
immunoglobulin class secreted by all three hybridomas was
mouse IgG3, with 5 to 10 ,ug of antibody per ml being
secreted. The MAbs reacted with various antigen prepara-
tions of P. haemolytica serotype 1 by ELISA (Table 1). The
MAbs failed to react to CPS after treatment with sodium-m-
periodate, indicating that these antibodies reacted with a
carbohydrate epitope in the CPS. The MAbs did not react
with either the periodate- or nontreated serotype 1-specific
capsular polysaccharide. Each MAb reacted with P. hae-
molytica serotype 1 LPS, and reactivity was lost after
periodate treatment. After acid hydrolysis of LPS, the MAbs
reacted more intensely with the core polysaccharide-0-
antigen moiety than with the lipid A (Table 1).
By SDS-PAGE and immunoblotting, all three MAbs re-
acted similarly with antigens in CPS and LPS, demonstrating
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TABLE 1. Reactivitya of MAbs with various P. haemolytica serotype 1 antigen preparations
Reactivity (A405)
Antigen MAb Control serab
E1F10 H6B5 H12E11 Positive Negative
CPS 1.881 1.912 1.951 >1.999 0.053
NaIO4 treated 0.135 0.229 0.164 1.857 0.126
LPS 1.006 0.999 0.932 0.750 0.028
NaIO4 treated 0.020 0.004 0.030 0.517 0.004
Capsular polysaccharide 0.008 0.002 0.008 0.431 0.013
NaIO4 treated 0.040 0.016 0.027 0.398 0.004
Lipid A 0.121 0.093 0.091 0.374 0.008
0-antigen 0.224 0.220 0.232 0.665 0.006
a Reactivity was measured by ELISA at an antigen concentration of 10 p.g/ml. The value of duplicate samples was expressed as A5.s minus the A405 of the PBS
control.
b Positive control sera were from CPS-hyperimmunized BALB/c mice. Negative control sera were from age- and sex-matched nonimmunized BALB/c mice.
multiple, equally spaced bands in a molecular size range of
14 to 25 kilodaltons (kDa) (Fig. 1). Periodate treatment of the
Western blots (immunoblots) of the CPS and LPS negated
this reaction.
The MAbs did not react with LPS from any other gram-
negative bacteria tested, including P. multocida type 3
(Table 2). However, each MAb had intense cross-reactivity
among P. haemolytica serotypes 1, 5, 6, 7, 8, and 12 and less
reactivity with serotypes 4 and 14 (Table 3). There was no
detectable binding with the other seven serotypes or the
untypable strain. Likewise, cross-reactivity was observed
with the MAbs among serotypes 1, 5, and 6 in an immuno-
blot (Fig. 2).
DISCUSSION
The three MAbs characterized in the present study re-
acted with CPS and LPS. Upon oxidation with sodium-m-
periodate, the reactivity seen against CPS and LPS was lost.
Periodate oxidation cleaves the carbohydrate-vicinal hy-
droxyl groups of the antigen without altering the structure of
the polypeptide chains (4). Therefore, loss of reactivity to
LPS after oxidation confirms the anticarbohydrate reactivity
of the MAbs and indicates that specificity is for the polysac-
charide component of LPS. Failure of the MAbs to react to
the serotype-specific capsular polysaccharide, which is not
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sensitive to periodate oxidation (1), and a more intense
reaction with the core-O-chain moiety of LPS than the lipid
A fraction support the concept that these MAbs are directed
against the polysaccharide moieties of LPS. Because of the
lack of reaction with LPS from gram-negative organisms
other than P. haemolytica in the present study, the MAbs
were specific for P. haemolytica LPS. Loss of reactivity of
the MAbs with CPS after periodate oxidation and the similar
LPS patterns for LPS and CPS observed with SDS-PAGE
immunoblotting indicate the presence of LPS in the CPS.
Previous studies with P. haemolytica serotype 4 (33)
indicated that acid hydrolysis cleaved the core oligosaccha-
ride (1.9 kDa) and 0-chains, which were then separable by
gel filtration. In the present study, the core-O-chain-rich
supernatant was dialyzed extensively in tubing with a 6- to
8-kDa size exclusion prior to use in the ELISA. This should
cause loss of free core molecules. Also, gel filtration of our
dialyzed core-O-chain supernatant produced only one major
peak greater than 6 kDa (J. A. Durham and B. A. Lessley,
29-
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FIG. 1. Immunoblot analysis of P. haemolytica serotype 1 CPS
antigens with MAbs. Lanes A to C, CPS was treated with sodium-
m-periodate prior to antibody incubation. Lanes D to F. CPS was
not treated with sodium-m-periodate. Lanes A and D, E1F1O; lanes
B and E, H6B5; lanes C and F, H12E11. Molecular weight markers
(103) are shown.
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FIG. 2. Immunoblot analysis of formalinized whole-cell prepara-
tions of P. haemolytica serotypes 1, 2, 5, 6, 9, and the untypable
strain with two MAbs, E1F1O (A) and H6B5 (B). Lane 1, Serotype
1; lane 2, serotype 2; lane 3, serotype 5; lane 4, serotype 6; lane 5,
serotype 9; lane 6, untypable strain. Approximate molecular weight
markers (103) are shown. The immunoblots are from two separate
gels, giving rise to the different molecular weight marker positions.
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TABLE 2. Reactivitya of MAbs produced against P. haemolytica serotype 1 with LPSs of various gram-negative bacteria
Reactivity (A405)
LPS source MAb Control sera'
ElF1O H6B5 H12E11 Positive Negative
Expt 1
Pasteurella haemolytica 1.006 0.999 0.932 0.750 0.028
Pasteurella multocida type 3 0.022 0.036 0.016 0.190 0.008
Serratia marcescens 0.008 0.025 0.004 0.126 0.002
Salmonella typhimurium 0.009 0.006 0.026 0.067 0.000
Klebsiella pneumoniae 0.006 0.023 0.002 0.122 0.000
Proteus vulgaris 0.008 0.015 0.019 0.149 0.004
Brucella abortus 19 0.000 0.019 0.005 0.066 0.022
Brucella abortus 2308 0.000 0.000 0.000 0.071 0.001
Expt 2
Pasteurella haemolytica 0.503 0.433 0.441 0.897 0.013
Escherichia coli 026:B6 0.015 0.004 0.010 0.277 0.009
Escherichia coli O55:B5 0.013 0.012 0.014 0.260 0.000
Escherichia coli O111:B4 0.006 0.011 0.016 0.116 0.021
Escherichia coli 0127:B8 0.007 0.005 0.004 0.177 0.012
Escherichia coli 0128:B12 0.001 0.000 0.003 0.193 0.002
Escherichia coli J5 0.010 0.008 0.013 0.130 0.004
Escherichia coli EH100 0.003 0.000 0.002 0.162 0.006
a As in Table 1, footnote a, but triplicate samples.
bSee Table 1, footnote b.
unpublished data), further supporting the observation that
the MAbs were directed against the 0-antigen of P. hae-
molytica.
Generally, the polysaccharide O-side chains of the LPS
molecule are responsible for serotype specificity among
many gram-negative organisms (9). However, in the present
study, the MAbs detected cross-reacting antigens among
several serotypes of P. haemolytica, supporting the concept
that P. haemolytica serotyping is based on capsular polysac-
charide or some other surface antigen and not LPS. Also,
TABLE 3. Reactivitya of MAbs against formalinized whole-cell
antigen preparations of other P. haemolytica serotypes'
Reactivity (A405)
Serotype or MAb Control serac
subunit
E1F1O H6B5 H12Ell Positive Negative
1 0.506 0.274 0.217 >1.999 0.297
2 0.000 0.010 0.004 >1.999 0.092
3 0.024 0.013 0.151 0.729 0.129
4 0.181 0.161 0.188 1.229 0.112
5 0.842 0.732 0.895 >1.999 0.202
6 1.474 1.043 1.318 >1.999 0.246
7 1.481 1.600 1.469 >1.999 0.199
8 >1.999 1.922 >1.999 >1.999 0.201
9 0.023 0.040 0.034 1.978 0.133
10 0.043 0.034 0.032 0.974 0.107
11 0.043 0.036 0.019 0.970 0.071
12 1.228 1.142 1.123 >1.999 0.249
13 0.011 0.024 0.011 1.581 0.110
14 0.348 0.315 0.349 1.086 0.002
15 0.010 0.013 0.006 0.731 0.012
Untypable 0.027 0.006 0.047 1.636 0.085
CPS >1.999 >1.999 >1.999 >1.999 0.354
a See Table 1, footnote a.
b When the plates were coated, concentrations were equivalent based on
A650 values of approximately 1.8.
' See Table 1, footnote b.
strong serologic cross-reactivity among P. haemolytica se-
rotypes 1, 5, 6, 7, 8, and 12 and, to a lesser degree, serotypes
4 and 14 indicates shared epitopes among their 0-antigens.
In a comparative study among five serotypes (1, 2, 5, 6, and
9) and one untypable strain of P. haemolytica, biological and
antigenic similarities among serotypes 1, 5, and 6 were
observed (M. J. Gentry, A. W. Confer, and S. G. Holland,
Vet. Microbiol., in press). In the present study, when
reacted against formalinized whole-cell preparations of se-
rotypes 1, 2, 5, 6, 9, and an untypable strain in an immuno-
blot, each MAb recognized similar antigenic areas among
serotypes 1, 5, and 6. The reactivity to the low-molecular-
weight bands indicates reaction to a fast-resolving antigen
located within the LPS. Burrells et al. (6) showed strong
cross-reactivity among serotypes 1, 2, 5, 6, 7, 8, 9, and 12 by
using a sodium salicylate extract of P. haemolytica. Salicy-
late extracts contain both protein and polysaccharide anti-
gens (15). Therefore, some of the serological cross-reactivity
seen by Burrells et al. (6) could be related to shared protein
epitopes as well as LPS. The cross-reactivity illustrated in
this paper suggests the presence of common LPS antigenic
determinants among several of the serotypes of P. haemoly-
tica.
Antibodies against LPS or the antigenic polysaccharide
chains have been associated with resistance to infection and
mortality due to various gram-negative organisms (25, 29). It
is questionable whether antibodies to LPS enhance resis-
tance to P. haemolytica (12). MAbs to the LPS of P.
haemolytica could be used to help further characterize the
role of LPS in the pneumonic pasteurellosis disease process,
including common binding sites and epitopes within the LPS
molecule. The MAbs from this study could be used in a
screening kit, such as latex bead agglutination, to rapidly
determine the presence of P. haemolytica in pneumonic
lesions or to determine whether P. haemolytica grown from
the nasal passages of cattle is low-virulence serotype 2 or a
more likely virulent serotype such as serotype 1, 5, or 6.
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